1st Quarter - Report
CEPHEID for CEPHEID
Firm
Client
Income
—
Expenses
$76,500
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6102/S. 3404 the Verifying Accurate and Leading-edge IVCT Development Act (VALID), H.R. 6074, Coronavirus Preparedness and Response Act, H.R. 6201 Families First Coronavirus Response Act, S. 3548 Coroavirus Aid, Relief, and Economic Security Act (CARES)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE M SCHOONMAKER | — |
| ANGELA STEWART New | Legislative Counsel, Senator John W. Warner (R-VA) |
Medicare/Medicaid MMM
Issues relating to the Laboratory Access for Beneficiaries (LAB) Act implementation; H.R. 6201 Families First Coronavirus Response Act, S. 3584 Coronavirus Aid, Relief, and Economic Security Act (CARES)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE M SCHOONMAKER | — |
| ANGELA STEWART New | Legislative Counsel, Senator John W. Warner (R-VA) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.